Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease
Blood Adv
.
2023 Jul 25;7(14):3680-3682.
doi: 10.1182/bloodadvances.2023009851.
Authors
Catherine R Hoyt
1
,
Andrew M Heitzer
2
,
Steven J Hardy
3
4
Affiliations
1
Program in Occupational Therapy, Departments of Pediatrics and Neurology, Washington University School of Medicine, St. Louis, MO.
2
Department of Psychology, St Jude Children's Research Hospital, Memphis, TN.
3
Divisions of Hematology and Oncology, Children's National Hospital, Washington, DC.
4
Departments of Pediatrics and Psychiatry & Behavioral Sciences, George Washington University School of Medicine & Health Sciences, Washington, DC.
PMID:
37058485
PMCID:
PMC10365932
DOI:
10.1182/bloodadvances.2023009851
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Anemia, Sickle Cell* / diagnosis
Anemia, Sickle Cell* / epidemiology
Anemia, Sickle Cell* / therapy
Cognition
Humans
Grants and funding
K23 HL161328/HL/NHLBI NIH HHS/United States
K23 HL141666/HL/NHLBI NIH HHS/United States
K12 HL137942/HL/NHLBI NIH HHS/United States